Johnson & Johnson will stop selling opioids in the US as part of $230 million settlement in New YorkBusiness Insider • 06/26/21
Johnson & Johnson agrees to stop selling opioids nationwide in $230 million settlement with New York stateCNBC • 06/26/21
The US is scrambling to send promised vaccines abroad after the same production plant that ruined millions of J&J vaccines also taints AstraZeneca shotsBusiness Insider • 06/19/21
Johnson & Johnson Building Case With New Patient Survival Data For Darzalex In Multiple MyelomaBenzinga • 06/14/21
JNJ's Imbruvica, AbbVie's Venclexta Combo Achieves Progression-Free Survival Of 78.4% Versus Gazyva-Chemo Cocktail In Leukemia PatientsBenzinga • 06/14/21
FDA Authorizes 10M JNJ COVID-19 Vaccine Doses, Asks To Discard 60M From Emergent Plant: NYTBenzinga • 06/11/21
J&J stock drops after report FDA said millions of COVID-19 vaccine doses need to be discardedMarket Watch • 06/11/21
The US government is blocking states from ordering Johnson & Johnson's COVID-19 vaccine so they can clear their backlog of unused dosesBusiness Insider • 06/11/21